ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord.
The ALS Report is based on Whole Genome Sequencing Test. As such, it analyzes all Common and Rare Variants associated with ASL, instead of a limited set of genes, like old genetic target panels.
Along with environmental factors, Genetics plays a key role in the regulation of ALS.
- 50 genes analyzed
- 100% genomic regions covered
- Intragenic and intergenic regions analyzed
- All variants reported